Anixa Biosciences (ANIX) EBIT Margin Growth (3y) (2014 - 2018)
Powered by 
Analysis
Anixa Biosciences (ANIX) EBIT Margin Growth (3y) (2014 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.43 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.61 Bn | 2.65 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.24 Bn | 1.44 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 1,354.00 |
| 10 | Anixa Biosciences | 92.04 Mn | 92.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2018 | 2,275.00 |
| Apr 30, 2018 | 834,616.00 |
| Jul 31, 2017 | -46,406.00 |
| Jul 31, 2015 | -131,130.00 |
| Apr 30, 2015 | -817,894.00 |
| Jan 31, 2015 | 23,974.00 |
| Oct 31, 2014 | 11,050.00 |
| Jul 31, 2014 | 25,471.00 |